Audit, tax and advisory services for global and emerging life science companies.
FORVIS delivers comprehensive resources to life science companies to support each phase of commercialization, from multinational pharmaceutical companies to pre-revenue companies seeking funding and navigating regulatory requirements. We bring our diverse skill set in collaboration with your company to help enable insightful growth, risk management and process optimization.
We can help you identify opportunities and risks along your growth journey, leveraging a nimble approach to guide your progress.
Assurance
Our life sciences assurance practice is experienced in working with a wide range of life science companies including pre-revenue, private equity-backed, publicly traded and multinational companies with global supply chains. Our assurance and related accounting services in the life sciences industry include:
- Accounting Standards Implementation
- Due Diligence Accounting for Acquisitions and Mergers
- Employee Benefit Plan Audits
- Financial Statement Audits and Reviews
- Goodwill and Intangible Assets Valuations
- Internal Audits & SOX Compliance
- IFRS Audits and Reporting
- IPO & SPAC Readiness
- Research Grant Audits Under Uniform Guidance
- Revenue Recognition for Arrangements with Multiple Performance Obligations
- SEC and Public Company Audits
Tax
From pre-revenue through commercialization and continued growth, we have the tax resources to help optimize your domestic and international tax posture along the way. Our tax services in the life sciences industry include:
- ASC 740 Income Tax Provisions
- Coordination of Foreign Country Compliance & Reporting
- Incentives & Credits Planning
- Multistate Planning & Nexus Studies
- Multinational Inbound & Outbound Tax Planning
- R&D Tax Credits
- Tax M&A Advisory
- Tax Return Preparation (Federal, State, Local, & International)
- Tax Transformation
- Transfer Pricing
Advisory
We have the risk, regulatory, and operational insight, plus investor relationships, to help life science companies grow and expand. Our consulting and advisory services to life science companies including:
- Business Combinations
- Capital, M&A and Exit Strategies
- Complex Equity Instruments and Share-Based Awards
- Corporate Finance Services
- Enterprise Risk
- ESG & Climate Risk
- Global Finance
- Government Contracting Consulting
- Internal Audit Strategy & Governance
- IT Risk & Cybersecurity
- Litigation & Valuation Services
- Performance & Process Improvement
- Quality of Earnings Reports (Buy Side and Sell Side)
- Supply Chain Optimization
Featured FORsights
New Lease Standard in M&A Negotiations
With U.S. private companies adopting ASC 842, see how the new standard may affect M&A transactions.
IRS Allows Automatic Method Change for Capitalizing R&D Expenses
The IRS has issued guidance for businesses to use the automatic accounting method change procedures to begin capitalizing and amortizing R…
Tailor-Made Solutions for Changing Times
Read Middle Market Executive’s article on how FORVIS can help clients excel in their business. See today.
Year-End Tax Matters for Tech, Life Sciences, & Services Companies
There are seven key tax considerations that companies in the technology, life sciences, and services sectors should be mindful of as they…
Are Your IT Systems Ready to Go Public?
Check out some specific technology needs that companies should assess when considering whether to become an SEC registrant.
FASB to Address Related-Party Lease Issues
Implementation efforts for Accounting Standards Codification (ASC) 842, Leases, are now underway for private companies.
Trusted Partner
FORVIS’ scalable resources will help support your growth, address risks and optimize operations at all stages.
